Related Experiment Video
Updated: Apr 26, 2026

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
The effect of a ceramide-containing dressing in preventing pressure ulcers
1Director of Samsung Medical Center International Wound Ostomy Continence Nursing Educational Program.
Objective:
To evaluate the effect of a ceramide-containing dressing (Remois Pad®) on preventing pressure ulcers.
Method:
A total of 32 patients (64 samples) with a Braden Scale score of 16 or less in intensive care units were enrolled to have the dressing applied for an experimental bilateral comparison study. The dressing was randomly applied to the right or left greater trochanter for 7 days. Incidence of nonblanching erythema and the water-holding capacity of the skin were measured on the third day and seventh day after intervention.
Results:
On the third day after intervention, nonblanching erythema was not apparent in either the experimental or the control groups. On the seventh day, one (3.3%) and four (13.3%) cases of nonblanching erythema were observed in the experimental group and the control group, respectively; however, the difference was not statistically significant. The water-retaining capacity of the skin on the third and seventh days after the intervention was significantly higher than that of the control group.
Conclusion:
The data collected from this study gave no evidence that a ceramide-containing dressing had an effect on preventing pressure ulcers in the greater trochanter area.
Declaration Of Interest:
There were no external sources of funding for this study. The authors have no conflicts of interest to declare.
More Related Videos
06:45Development of a Benchtop Model for Evaluating the Compatibility of Wound Dressing Materials with Negative Pressure Wound Therapy Systems
Published on: May 2, 2025
04:09Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
Related Concept Videos
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Diabetic Foot Ulcer
Peripheral Artery Disease IV: Nursing Management
Clinical Applications of Epidermal Stem Cells
Healing II: Complications
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...